- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02942719
The Establishment and Application of the New Labor Progress Centered System of Reducing Cesarean Section Rates in China
October 21, 2016 updated by: Shanghai First Maternity and Infant Hospital
- To describe the average labor curve and establish new labor progression standards.
- Cesarean section rates: Based on big data, the investigator will introduce the international advanced Robson class method and identify the appropriate level of cesarean section rate for each type population.
- Establishment of "Chinese maternal-fetal medical collaboration network" and APP to promote natural childbirth.
Study Overview
Status
Unknown
Conditions
Detailed Description
- To describe the average labor curve and establish new labor progression standards. The investigator will investigate the current characteristics of obstetric population and the labor progression with obstetric intervention in China. The investigator compare the different effects of traditional labor progression management model, new labor progression management model and active labor progression management model on labor outcomes. Based on the best outcomes of maternity and infants, the investigator will establish and modify new labor progression which is suitable for Chinese.
- Cesarean section rates: Based on big data, the investigator will introduce the international advanced Robson class method and identify the appropriate level of cesarean section rate for each type population.the investigator compare cesarean section rates of different level hospitals and evaluate the effects of reducing cesarean section rates. The investigator also analyze the risk factors of cesarean section rates of the ten Robson classification, which will provide basis for reducing cesarean section rates under the new strategy.
- Establishment of "Chinese maternal-fetal medical collaboration network" and mobile application software (APP) to promote natural childbirth: The investigator establish perinatal data center using the hospital information system (HIS) system of hospital. The investigator predict the cesarean section rates and relative factors using the Robson classification method, and propose the new strategy of reducing cesarean section rates. Meanwhile, the investigator develop the quality management system toolkit which can help clinicians standardize behavior and improve obstetric safety.
Study Type
Observational
Enrollment (Anticipated)
15000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tao Duan, Ph.D
- Phone Number: 13371985019
- Email: tduan@yahoo.com
Study Contact Backup
- Name: Jing Hua, Ph.D
- Phone Number: 13661504752
- Email: szhuaj@hotmail.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 201204
- Recruiting
- Shanghai first maternity and infant hospital
-
Contact:
- Jing Hua, Ph.D
- Phone Number: 13661504752
- Email: szhuaj@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
A total of 20 hospitals from different places of China participated this study.
Their annual delivery amount are more than 5000 times and their cesarean section rates are about 40%.
The labor progression study include a total of 15,000 puerperae.
Description
Inclusion Criteria:
- Chinese pregnant women
- singleton
- head position
- 37 weeks + 0 day - 41weeks + 6 days
- primipara
- low-risk pregnancy
- vaginal delivery willingness
- vaginal cervix <7 cm after labor
Exclusion Criteria:
- multiple pregnancy
- non-head position
- stillbirth
- selective cesarean section
- prenatal cesarean section
- age <18 years
- previous childbirth history
- pregnancy complications
- important fetal malformations.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Shanghai First Maternity and Infant Hospital
|
Dalian Maternity and Child Health Hospital
|
Beijing Obstetrics and Gynecology Hospital
|
Shijiazhuang Obstetrics and Gynecology Hospital
|
The Children and Women's Healthcare of Laiwu City
|
Suzhou Municipal Hospital
|
Wenling Women's and Children's Hospital
|
First Affiliated Hospital of Kunming Medical University
|
Changsha Hospital for Maternal and Child Health Care
|
Xinxiang Maternity and Child Health Hospital
|
Yanshi People's Hospital
|
The Maternal and Child Health Hospital of Guangxi
|
Northwest Women and Children's Hospital
|
Suining Central Hospital
|
Inner Mongolia Maternity and Child Health Hospital
|
Fujian Province Maternity and Child Health Hospital
|
Qinghai Red Cross Hospital
|
Xinjiang Maternity and Child Health Hospital
|
Jiangmen Maternity and Child Health Care Hospital
|
Gansu Provincial Maternity and Child-care Hospital
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
times of uterus contraction
Time Frame: 10 minutes
|
The investigator count the times of uterus contraction in 10 minutes both intrapartum and postpartum.
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
fetal heart rate
Time Frame: 1 minute
|
Normal resting fetal heart rate is approximately 120-160 times per minute.
|
1 minute
|
blood pressure
Time Frame: 10 minutes
|
Blood pressure is the pressure exerted by circulating blood upon the walls of blood vessels.
It is usually expressed in terms of the systolic (maximum) pressure over diastolic (minimum) pressure and is measured in millimeters of mercury (mmHg).
Normal resting systolic (diastolic) blood pressure in an adult is approximately 120 mmHg (80 mmHg), abbreviated "120/80 mmHg".
|
10 minutes
|
Apgar scores
Time Frame: 1 minute and 5minutes
|
The Apgar scale is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained.
The resulting Apgar score ranges from zero to 10.
|
1 minute and 5minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tao Duan, Ph.D, Shanghai First Maternity and Infant Hospital Tongji University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Anticipated)
December 1, 2018
Study Completion (Anticipated)
December 1, 2018
Study Registration Dates
First Submitted
October 18, 2016
First Submitted That Met QC Criteria
October 21, 2016
First Posted (Estimate)
October 24, 2016
Study Record Updates
Last Update Posted (Estimate)
October 24, 2016
Last Update Submitted That Met QC Criteria
October 21, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMIH Duan
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
There are 20 hospitals participated this study, we need get their agreement to share data.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Complications
-
The Cooper Health SystemRecruitingPregnancy,Neoplastic ComplicationsUnited States
-
Northwestern UniversityTerminatedPregnancy Related | Labor ComplicationUnited States
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Terminated
-
Jazz PharmaceuticalsRecruitingPregnancy | Pregnancy Complication | Maternal Complications | Birth Outcomes, AdverseUnited States
-
Oslo University HospitalRecruitingPregnancy Related | Labor Complication | Induced; BirthNorway
-
Washington University School of MedicineUniversity of MichiganRecruiting
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompleted
-
Thomas Jefferson UniversityCompleted
-
University Hospital Center of MartiniqueCompletedLabor Complication | CervixMartinique
-
PerspectumUniversity of Oxford; Fetal Medicine FoundationCompletedPregnancy Complications | Fetal Growth ComplicationsUnited Kingdom